BFLY

Butterfly Network, Inc.

Founded by Dr. Jonathan Rothberg in 2011, Butterfly has created the world\'s first handheld, single-probe whole-body ultrasound system using its patented Ultrasound-on-Chip™ semiconductor technology. Butterfly\'s mission is to democratize medical imaging and contribute to the aspiration of global health equity, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ can be purchased today by healthcare practitioners in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. Butterfly iQ is a prescription device intended for trained and qualified healthcare professionals only.

Butterfly Network, Inc. (BFLY) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.

Quantitative Factor Evaluation • Updated

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 B- (2.9) B- (2.9) C+ (2.8) B (3.3) C+ (2.6) B- (2.9)
2026-11-10 B- (2.9) B- (2.9) C+ (2.8) B (3.4) C+ (2.6) B- (2.9)
2026-11-03 B- (2.9) B- (3.0) C+ (2.8) B (3.3) C+ (2.7) B- (2.9)
2026-10-27 B- (2.9) C+ (2.8) C+ (2.8) B (3.3) C+ (2.6) B- (2.9)
2026-10-20 B- (2.9) C+ (2.8) C+ (2.8) B (3.2) C+ (2.6) B- (2.9)

Showing the last month only. Subscribe for the full factor score history.

For more — Subscribe